The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Lacosamide for neuropathic pain and fibromyalgia in adults
|
|---|---|
| Published in |
Cochrane database of systematic reviews, February 2012
|
| DOI | 10.1002/14651858.cd009318.pub2 |
| Pubmed ID | |
| Authors |
Leslie Hearn, Sheena Derry, R Andrew Moore |
| Abstract |
Antiepileptic drugs have been used in pain management since the 1960s; some seem to be especially useful for neuropathic pain. Lacosamide is an antiepileptic drug that has recently been investigated for neuropathic pain relief, although it failed to get approval for painful diabetic peripheral neuropathy from either the Food and Drug Administration or the European Medicines Agency. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 33% |
| United Kingdom | 2 | 22% |
| New Zealand | 1 | 11% |
| Switzerland | 1 | 11% |
| Unknown | 2 | 22% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 78% |
| Science communicators (journalists, bloggers, editors) | 2 | 22% |
Mendeley readers
The data shown below were compiled from readership statistics for 218 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | <1% |
| United Kingdom | 1 | <1% |
| France | 1 | <1% |
| Unknown | 214 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 39 | 18% |
| Researcher | 23 | 11% |
| Student > Bachelor | 18 | 8% |
| Other | 14 | 6% |
| Student > Doctoral Student | 14 | 6% |
| Other | 43 | 20% |
| Unknown | 67 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 72 | 33% |
| Nursing and Health Professions | 20 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 6% |
| Psychology | 10 | 5% |
| Agricultural and Biological Sciences | 6 | 3% |
| Other | 27 | 12% |
| Unknown | 71 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 August 2023.
All research outputs
#2,667,329
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#5,258
of 11,499 outputs
Outputs of similar age
#20,546
of 258,519 outputs
Outputs of similar age from Cochrane database of systematic reviews
#66
of 204 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has gotten more attention than average, scoring higher than 54% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 258,519 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 204 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.